Tissue Regenix Share Discussion Threads

[cyberbub] 11/5/2022 18:16

Clocktower I know what you mean... Maybe we should ask the company if they give shareholders big discounts on regenerated bone and soft tissue operations?? :-)

[clocktower] 11/5/2022 12:04

Ben - if you had as many millions shares of this and others, you may also check your whole portfolio daily while lying in the sunshine or fishing, with not a lot of better things to do, because age and health start to limit life regrettably.

[bennnjaminnn] 10/5/2022 18:10

Most people are holding. I have just over a million shares, unfortunately at an average of .576p, got in a bit late. Just chill out, stop checking everyday and see out the year when (if) they become profitable and re-evaluate.

[clocktower] 10/5/2022 14:30

Still no meaningful support, at what level will it kick in once again?

Less than £25k worth most days send it sliding slowly backwards. Its been a while since even 20 million shares a day were traded.

[clocktower] 09/5/2022 12:47

The market is so weak but I added a lot far to soon it seems but when the bounce in the market comes or we get very positive news, I guess it will bounce in a flash.

I was going to add from profits but some of those are slipping away today, so its a case of sitting on ones hands, as I already have a very large amount of these.

[cyberbub] 09/5/2022 12:23

Surprised it's dipped further. No major news forecast I suppose = share price drift, plus a poor wider market.

[clocktower] 06/5/2022 13:38

Decided to buy more today, hopefully it will recover soon or I will keep adding.

[clocktower] 06/5/2022 09:32

Disappointing to see the continued fall but not unexpected in view of the fall in the US market.

[clocktower] 04/5/2022 12:27

A little top up of 265k at 0.483 today with profits from elsewhere, as the long term value should keep growing imo.

Plenty of buys have been showing as sells for a fair time now.

[clocktower] 03/5/2022 09:17

Good morning folks, lets hope you all had a good Bank Holiday weekend.

Cerrito, Good to see your contribution to the thread but I was just wondering what else is your pillow laced with, as it seems to keep you up late, or should I say to the early hours.

I expect that once you have consulted, you will take appropriate action, and in a few months time be saying the same thing about those buying at under 0.55 as did the last company director.

However, they have purchased at much higher levels before.

Yes, it would be good to hear from anyone that was at the AGM and get a general report from them, as to numbers present and the general mode etc.

Try lavender under the pillow case or CBD oil that might help. :-)

[cerrito] 03/5/2022 00:27

Did anyone make the AGM??? Did I gather GSG from your 7138 that you did? Any feedback?. As an ex Consort shareholder I was always impressed by the presentations that Glen gave.
Hats off to them by not following the example of many AIM companies who are continuing to hide behind Covid restrictions.
I have to admit that I was too disorganized myself to make it.
I saw that their AGM proposals were voted by North Korea style majorities but also noted that 3b of the 7b shares voted…high by AIM standards but suggests that one of the 5 largest shareholders all of whom are pretty activist did not vote their shares. We need to hope that neither Lombard Odier, Harwood Capital, Richard Griffiths, P Miton or IP Group lose patience and start selling as it would be difficult to absorb the shares.
Reassuring that no Change of Holdings RNS since last October when IP downsized by 4pc and Harwood Capital( who of course take no prisoners)picked them up. That said I was not best pleased to see that on the website they have Premier Miton with 9.88% holding at 3.11.21 and in the annual report they had Premier Miton’s holding at 7.45% and no RNS.

Also just organized myself to listen to the IMC presentation. Good given the share price and the current cable rate they do not anticipate having to do an equity raise. I was interested to hear how closely their fortunes are tied to elective surgery.
Too bad I cannot find any research on them on Research Tree.
In the meantime, we go on the basis that they have no suppliers of key components based in Shanghai, Jilil etcet.
I see that trading volumes in April were the lowest for the last year…although Easter would have something to do with it.
Well done to those on the ball to buy in the mid thirties a few weeks back and I am about to consult with my pillow if the current £35m marcap is appropriate to buy more.

[emeraldzebra] 29/4/2022 13:35

Stupid question from a dinosaur/novice : Occasionally very small volumes (I.E. in the hundreds) are bought/sold. Why would such trades be worthwhile in a share like this which is worth less than a penny ?

[cliffpeat] 29/4/2022 06:00

@marktime1231
Thanks for interesting post.

A YouTube search on "scaffold + stem cell treatment" shows an overwhelming and encouraging number of videos.

Evidently there is a lot of activity in this area of medical research - and because of regulatory rules, results take time. So may be worth looking at some of the older ones as well as recent.

Can you identify any videos relating to TRX activities specifically?

[marktime1231] 28/4/2022 17:41

Yes TRX demand from elective and clinical treatments, and ACL repair is crying out for something better than grafting a hamstring or patella tendon. I saw a video of how effective scaffold + stem cell treatment can be repairing a soft tissue foot injury, the science is jaw dropping. Unfortunately covid clobbered the market just as TRX scaled up capacity but hopefully we will start to see the business take off now.

*augurs

[tnt99] 28/4/2022 13:39

Good 1/4 results from smith and nephew in the elective surgery space orgers well for tissue regenix as in the same space they start a large increase in their elective surgery of hips etc in the last quarter as covid cases reduce!!!

[clocktower] 28/4/2022 13:24

After the presentation tomorrow we might see more movement (hopefully) and maybe another rns before long about other good news.

Conclusions of presentation :

"Patients undergoing primary ACLR with a novel xenograft implant (OrthoPure®XT ligament reconstruction implant) showed appropriate clinical safety and clinical performance at 48 months following treatment with the implant. Presented outcomes are in line with clinical expectations following primary ACL reconstruction. OrthoPure® XT might provide an alternative graft choice for ACL reconstruction and other ligament reconstructions, further studies are planned to evaluate this."

Time of Mr Hunts slot.

FP27-09 FIRST IN HUMAN CLINICAL DATA FROM A NOVEL XENOGRAFT BIOLOGIC SCAFFOLD USED TO TREAT PRIMARY ACL RECONSTRUCTION. 24 & 48 MONTH FOLLOW-UP
Neil Hunt (United Kingdom)
15:33 – 15:39
6 min
incl. 1 min discussion

[clocktower] 28/4/2022 11:10

A few more snips of info and presentations from the company will soon have a major positive impact.

It is interesting to watch the MM game going on today and it seems the doors open once again.

[cliffpeat] 28/4/2022 08:55

About Neil Hunt:



Encouraging to have such a qualified participant.

[clocktower] 28/4/2022 08:54

GSG, I am not surprised but I can only set my target on the research and information that I have received. However I do not doubt that you maybe correct, and I may up my target as more information and results becomes available, as this is now a longer term hold for me.

MM keeping the lid shut this morning, I believe they may be very short of stock.

[gsg] 28/4/2022 08:30

clocktower.

Having met the top team earlier this week, my target is double yours.

[clocktower] 28/4/2022 08:11

I like the way they have released this news, very understated. I expect it will soon attract the micro fund managers, as the presentation to such a massive market will have such a positive effect.

I am now raising my target to 1p.

I am pleased that I had another nibble yesterday
.

[gsg] 28/4/2022 07:54

A massive market indeed for OrthoPure®XT.